Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: A Department of Veterans Affairs Cooperative Study

Arthritis and Rheumatism

Volumn 42, Issue 11, 1999, Pages 2325-2329

  Clegg, Daniel O ^a,c   Reda, Domenic J ^b   Abdellatif, Mazen ^b  

^a UNIVERSITY OF UTAH   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SALAZOSULFAPYRIDINE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; RANDOMIZED CONTROLLED TRIAL; REACTIVE ARTHRITIS; SPONDYLOARTHROPATHY; TREATMENT OUTCOME;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, PSORIATIC; ARTHRITIS, REACTIVE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PLACEBOS; SEROLOGIC TESTS; SPONDYLITIS, ANKYLOSING; SUBSTANCE WITHDRAWAL SYNDROME; SULFASALAZINE; TREATMENT OUTCOME;

EID: 0033511186     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C     Document Type: Article

References (13)

1. Clegg DO, Reda DJ, Weisman MH, Blackburn WD, Cush JJ, Cannon GW, et al. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis: a Department of Veterans Affairs cooperative study. Arthritis Rheum 1996;39:2004-12.
2. Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T, et al. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis: a Department of Veterans Affairs cooperative study. Arthritis Rheum 1996;39:2013-20.
3. Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR Jr, et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome): a Department of Veterans Affairs cooperative study. Arthritis Rheum 1996;39: 2021-7.
4. Amor B, Kahan A, Dougados M, Delrieu F. Sulfasalazine and ankylosing spondylitis [letter]. Ann Intern Med 1984;101:878.
5. Fraser SM, Sturrock RD. Evaluations of sulphasalazine in ankylosing spondylitis - an interventional study. Br J Rheumatol 1990; 29:37-9.
6. SAS Institute. SAS technical report P-229. SAS/STAT: changes and enhancements, release 6.07. Cary (NC): SAS Institute; 1992.
7. SAS Institute. SAS/STAT user's guide: version 6. 4th ed. Cary (NC): SAS Institute; 1990.
8. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthopathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
9. Symmons DPM, Salmon M, Farr M, Bacon PA. Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis. J Rheumatol 1988;15:575-9.
10. Nissilä M, Lehtinen K, Leirisalo-Repo M, Luukkainen R, Mutru O, Yli-Kerttula U. Sulfasalazine in the treatment of ankylosing spondylitis: a twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum 1988;31:1111-6.
11. Selhub J, Dhar J, Rosenberg IH. Inhibition of folate enzymes by sulfasalazine. J Clin Invest 1978;61:221-4.
12. Franklin JL, Rosenberg IH. Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidiine). Gastroenterology 1973;64:517-25.
13. Mielants H, Veys EM, Joos R. Sulphasalazine (salazopyrin) in the treatment of enterogenic reactive synovitis and ankylosing spondylitis with peripheral arthritis. Clin Rheumatol 1986;5:80-3.